Skip to main content

Day: September 14, 2021

Mason Graphite Announces Commercial Usage of Black Swan Graphene Product in Concrete

MONTREAL, Sept. 14, 2021 (GLOBE NEWSWIRE) — Mason Graphite Inc. (“Mason Graphite” or the “Company”) (TSX.V: LLG; OTCQX: MGPHF) is pleased to announce that graphene resulting from the patented process owned by Black Swan Graphene Inc. (“Black Swan”), and produced by Black Swan’s strategic shareholder Thomas Swan & Co., was recently used in the concrete mix poured during the construction of a large residential development in the United Kingdom. An accelerated video of the construction is available below. Nationwide Engineering Group, a construction focused service provider with dedicated integrated companies, has used the graphene-enhanced concrete developed by Concretene, a whole owned subsidiary, in a £17.5M (CA$30.5M) residential development in Salisbury, 150 km west of London, England. Concrete is one of...

Continue reading

Beyond Air® to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

GARDEN CITY, N.Y., Sept. 14, 2021 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid tumors, today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, is scheduled to present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held virtually from September 20th to 23rd. Presentation Details:Date and Time: Wednesday, September 22, 2021 at 9:05 AM – 9:45 AM ETWebcast: https://wsw.com/webcast/oppenheimer16/xair/2791100Participation: Management will participate in additional 1-on-1 meetings...

Continue reading

American Green (OTC:ERBB) Launches on eBay™ Featuring the Company’s Premium Hemp Cream and Hemp Lip Balm

PHOENIX, AZ, Sept. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Today American Green (ERBB:OTC) announced that it has begun selling its Premium Hemp Cream and Hemp Lip Balm by expanding its E-commerce presence on eBay.com. The company is excited to add sales from eBay as another revenue stream and plans to meet or exceed the success it is currently enjoying following its launch on Amazon.com last December. David G. Gwyther, American Green’s president, said, “We are thrilled to offer our premium hemp products on ebay.com.  Our products will be made available with eBay’s “Buy it Now” function and will include free shipping to all US customers.   Consumers throughout the world will now have direct access to American Green’s premium hemp products on eBay.com.”  Ebay currently has over 185 million users worldwide. “Over the...

Continue reading

CloudMD Partners with 19 New Post-Secondary Institutions to Provide Integrated Mental Health Support Programs to Students

CloudMD’s Aspiria SAP is a leading student mental health provider in Canada Adds over 167,000 new students to CloudMD platform Increases partner network to 141 K-12 and post-secondary institutions across Canada Various sizes ranging from 200 students to 48,000 studentsVANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) (the “Company” or “CloudMD”), a healthcare technology company revolutionizing the delivery of care, is excited to announce that it has partnered with 19 new post-secondary institutions across Canada to provide its Aspiria Student Assistance Program (“Aspiria SAP”) and multi-layered mental health resources to over 167,000 additional students. With growing mental health concerns surrounding the pandemic and students returning...

Continue reading

Opendoor Technologies Inc. Announces Pricing of Secondary Public Offering by Selling Stockholder

SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Opendoor Technologies Inc. (Nasdaq: OPEN) (“Opendoor”), a leading digital platform for residential real estate, today announced the pricing of its previously announced registered secondary public offering of 28,000,000 shares of common stock by an existing stockholder of Opendoor (the “Selling Stockholder”). The Selling Stockholder has also granted the underwriter a 30-day option to purchase up to an additional 4,200,000 shares of common stock from the Selling Stockholder. Opendoor is not selling any shares and will not receive any proceeds from the offering, which is expected to close on September 16, 2021, subject to customary closing conditions. Citigroup Global Markets Inc. is acting as sole book-running manager for the offering. Citigroup proposes to offer the shares of common...

Continue reading

Benjamin Hill Files 43-101 Technical Report for the Benjamin Hill Property

VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — Benjamin Hill Mining Corp. (CSE: BNN) (OTCBB: BNNHF) (“BHM” or the “Company”) is pleased to announce that on September 14, 2021 it filed on SEDAR a National Instrument 43-101 compliant technical report (“Technical Report”) titled: ‘NI 43-101 Technical Report on the Benjamin Hill Property’ consisting of the Sonora Gold and Sonora Copper concessions in the State of Sonora, Mexico. The report’s effective date is July 25, 2021. The report summarizes the geological setting, mineralization and exploration activities carried out by Benjamin Hill Mining Corp on the Benjamin Hill Property in the past year. The Benjamin Hill project hosts an extensive hydrothermal system enriched in Au, Ag and Cu that is exposed at surface. Mineralization occurs as sets of vein systems, hydrothermal...

Continue reading

Zai Lab Announces Breakthrough Therapy Designation Granted for Bemarituzumab (FPA144) in China

Potential first-in-class therapy for a subset of gastric and gastroesophageal (GEJ) cancers that overexpress fibroblast growth factor receptor 2 (FGFR2b) SHANGHAI and SAN FRANCISCO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) granted Breakthrough Therapy Designation for investigational bemarituzumab (FPA144), for first-line treatment for patients with FGFR2b overexpressing and human epidermal growth factor receptor (HER2)-negative metastatic and locally advanced gastric and GEJ cancers in combination with modified FOLFOX6 (fluoropyrimidine, leucovorin, and oxaliplatin). “In granting Breakthrough Therapy Designation, we are pleased...

Continue reading

Progenity Announces Patent Granted by USPTO for its Preeclampsia Rule-Out Test

SAN DIEGO, Sept. 14, 2021 (GLOBE NEWSWIRE) — Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 11,112,403 for assessment of preeclampsia using assays for free and dissociated placental growth factor. The patent is directed to methods, compositions, and kits for detecting and measuring free and dissociated placental growth factor (PlGF) levels in biological samples. PlGF is well established as an important biomarker for the assessment of preeclampsia, and recent studies have revealed the importance of distinguishing between the free and bound forms when assessing the complex physiological pathways involved in preeclampsia. “We are pleased the USPTO has granted this patent covering unique and novel methods for...

Continue reading

AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma

BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today issued a letter to its shareholders from James Sapirstein, President, Chief Executive Officer and Chairman, regarding its recently announced merger with First Wave Bio, Inc. and adoption of the First Wave BioPharma name. The full text of the letter, which has also been posted to the Company’s website, is as follows: Dear Shareholders, It is with great excitement and enthusiasm that I write to you, the shareholders of the new First Wave BioPharma. Yesterday, as AzurRx BioPharma, we announced our acquisition of First Wave Bio, Inc. (“First Wave...

Continue reading

exactEarth Announces Q3 Fiscal 2021 Financial Results and Agreement to be Acquired by Spire Global

– exactEarth has entered into an agreement to be acquired by Spire Global for $204.2 million in cash and equity – Consideration of $3.90 per share represents a premium of 171% to exactEarth’s 10-day VWAP of $1.4417 per share CAMBRIDGE, Ontario, Sept. 14, 2021 (GLOBE NEWSWIRE) — exactEarth Ltd. (“exactEarth” or “the Company”), a leading provider of Satellite-AIS data services, announces its financial results for the three- and nine-month periods ended July 31, 2021. All financial figures are in Canadian dollars unless otherwise stated. Q3 and Year-to-Date Fiscal 2021 Highlights:Revenue was $6.0 million, up 26% compared to $4.8 million in Q3 2020; revenue Year-to-Date (“YTD”) was $17.3 million, up 30% compared to $13.3 million in the same period last year. Subscription Services1 revenue was $5.3 million, up 18% compared...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.